Arcus Biosciences
RCUS
RCUS
75 hedge funds and large institutions have $235M invested in Arcus Biosciences in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 78 → 75 (-3)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
75
Holding in Top 10
3
Calls
–
Puts
$1K
Top Buyers
| 1 | +$6.06M | |
| 2 | +$3.11M | |
| 3 | +$2.76M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$2.73M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.41M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$6.68M | |
| 3 | -$2.15M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$993K |
| 5 |
Morgan Stanley
New York
|
-$799K |